Immunomodulation - hope for patient with Glioblastoma Multiforme
AbstractGlioblastoma multiforme is the most common and highly aggressive brain tumor, causing high number of death worldwide. Current therapies are not sufficient for patients. The surgical removal followed by radio- and chemotherapy became golden standard. Overall survival is still disappointing. New approach to GBM therapy is required . Immunotherapy seems to be a proper direction .
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 88
Number of citations: 0